CAN TTF1 STAINING BE USED AS SELECTION FOR EGFR-MUTATION ANALYSIS IN PATIENTS WITH LUNG CANCER?

被引：0
|
作者：
Vincenten, Julien [1 ]
Smit, Egbert F. [1 ]
Vos, Wim [2 ]
Grunberg, Katrien [2 ]
Postmus, Pieter E. [3 ]
Heideman, Danielle [4 ]
Snijders, Peter J. [4 ]
Meijer, Gerrit A. [4 ]
Kuik, Dirk J. [2 ]
Thunnissen, Erik [2 ]
机构：
[1] Vrije Univ Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
lung carcinoma; TTF1; EGFR mutation; TRU;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S443 / S444
页数：2
相关论文
共 50 条
  • [1] Some Lung Cancer Patients End up without an EGFR-Mutation Analysis
    Berg, Janna
    Suhrke, Pal
    Fjellbirkeland, Lars
    Brustugun, Odd Terje
    Helland, Aslaug
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S707 - S707
  • [2] Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non-Small-Cell Lung Cancer
    Vincenten, Julien
    Smit, Egbert F.
    Vos, Wim
    Gruenberg, Katrien
    Postmus, Pieter E.
    Heideman, Danielle A. M.
    Snijders, Peter J. F.
    Meijer, Gerrit
    Kuik, Joop
    Witte, Birgit I.
    Thunnissen, Erik
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1522 - 1527
  • [3] Mutation analysis and association with TTF1 expression in lung non-squamous NSCLC
    Kret, A.
    Clark, C.
    Tennant, S.
    Nicolson, M.
    Kerr, K. M.
    LUNG CANCER, 2015, 87 : S16 - S16
  • [4] NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer
    Borie, Raphael
    Funalot, Benoit
    Epaud, Ralph
    Delestrain, Celine
    Cazes, Aurelie
    Gounant, Valerie
    Frija, Justine
    Debray, Marie-Pierre
    Zalcman, Gerard
    Crestani, Bruno
    ERJ OPEN RESEARCH, 2021, 7 (04)
  • [5] Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinib
    Mensah, Samuel Akaakole
    Ahmad, Syed
    Alruwaili, Waleed
    Raval, Rutu
    Gonuguntla, Karthik
    Patel, Brijesh
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [6] TEAD single nucleotide polymorphism affects PFS in EGFR-mutation positive lung cancer patients treated with EGFR TKIs
    Yamazoe, Masatoshi
    Ozasa, Hiroaki
    Ogimoto, Tatsuya
    Hosoya, Kazutaka
    Ajimizu, Hitomi
    Yamamoto, Tomoko
    Tsuji, Takahiro
    Itotani, Ryo
    Sakamori, Yuichi
    Nomizo, Takashi
    Yoshida, Hiroshi
    Hashimoto, Kentaro
    Hirai, Toyohiro
    CANCER SCIENCE, 2022, 113 : 1014 - 1014
  • [7] TTF-1 and EGFR expression are related to EGFR mutation in lung adenocarcinoma
    Chen, Changhao
    Shen, Dong
    Li, Jie
    Sun, Yuejun
    Wang, Jiandong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (09): : 4650 - 4656
  • [8] Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Mori, Kazutaka
    Iwashita, Yuji
    Kahyo, Tomoaki
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Inui, Naoki
    Funai, Kazuhito
    Shinmura, Kazuya
    Niwa, Hiroshi
    Suda, Takafumi
    Sugimura, Haruhiko
    GENES CHROMOSOMES & CANCER, 2017, 56 (07): : 570 - 581
  • [9] Clinical Outcome and Toxicity Profiles of Patients with EGFR-mutation Positive Non-Small-Cell Lung Cancer
    Munawar, K.
    Sheikh, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S621 - S622
  • [10] Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer
    Ito, Masaoki
    Codony-Servat, Cartes
    Karachaliou, Niki
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (05) : 667 - +
12345